Drug adulteration is banned in the United States due to frequent scandals in Indian pharmaceutical industry

September 17, 2013 source: Netease News pharmaceutical industry is an important industry in India, with an annual export volume of nearly 15 billion US dollars India is the country with the largest number of FDA certified drugs except for the United States However, India's pharmaceutical industry has been plagued by scandals According to Agence France-Presse 16, the FDA decided to stop importing products from a factory owned by India's pharmaceutical giant rambersey laboratory, which led to the company's share price falling nearly 35% early Monday The FDA issued a warning on Friday against a factory of rambersey laboratory in Punjab In May, the lab accepted charges from the U.S that it sold antibiotics, acne and epilepsy drugs mixed with secondary products The 8-year-old adulteration was uncovered by a former employee of the company A spokesman for the lab has yet to respond In recent months, India's pharmaceutical industry has been subject to strict control by regulators around the world due to product problems In July, British health regulators recalled 16 drugs from India's whagenhard pharmaceutical company According to KPMG's report released last year, the annual compound growth rate of Indian pharmaceutical industry in the past five years has reached 15% In terms of output, Indian pharmaceutical industry accounts for 1 / 4 of the world; in terms of output value, Indian pharmaceutical industry accounts for 1 / 13 of the world; in terms of drug consumption, Indian pharmaceutical market accounts for 8% of the global pharmaceutical market, ranking fourth in the world